Skip to content

Mechanisms of psilocybin on the treatment of posttraumatic stress disorder

Charles Q. Choi, Danica E. Johnson, David C J Chen-Li, Joshua D. Rosenblat

Journal of Psychopharmacology October 3, 2024 DOI: 10.1177/02698811241286771 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Intervention Psilocybin
Topics Anxiety Psilocybin PTSD
Keywords Posttraumatic stress Arousal Hallucinogen Mood Pharmacotherapy Psychotherapist Clinical psychology Cognition Exposure therapy
Citations 11
Key findings Psilocybin may be an underexplored treatment option for PTSD, though further research is required.

Abstract

Posttraumatic stress disorder (PTSD) is a condition that can develop after a traumatic event, causing distressing symptoms, including intrusive re-experiencing symptoms, alterations in mood and cognition, and changes in arousal and reactivity. Few treatment options exist for patients who find conventional psychotherapy and pharmacotherapy to be inaccessible, ineffective, or intolerable. We explore psilocybin as a potential treatment option for PTSD by examining the neurobiology of PTSD as well as psilocybin’s mechanism of action. Based on both pharmacodynamic and psychoanalytic principles, psilocybin may be an underexplored treatment option for patients with PTSD, though further research is required.

In the evidence

This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.

  • Argues that psilocybin may be an underexplored treatment option for PTSD based on its mechanism of action, though further research is required.

    Synthesized

Comparable studies

Other narrative reviews on psilocybin for PTSD, most cited first.

Explore topics

By condition and practice